Mitiglinide calcium hydrate
Product Specifications
CAS Number
207844-01-7
Target
Potassium Channel
Related Pathways
Membrane transporter/Ion channel
Purity
>99.99%
Bioactivity
Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K (+) K (ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
Smiles
[Ca++].[O-]C(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1.[O-]C(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1
Molecular Formula
C38H52CaN2O8
Molecular Weight
704.91
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-20773R-PerCP-Cy5.5 100 µL
Caspase-9 Polyclonal Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details 